OrthoPediatrics Corp. Announces Closing of Offering of Common Stock

Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced the closing of its underwritten public offering of 1,600,000 shares at a price of $47.00 per share, generating approximately $75.2 million in gross proceeds. The offering was facilitated by Piper Sandler and Stifel as joint book-running managers, with additional support from other firms. The shares were offered under a shelf registration statement effective since March 27, 2020. A final prospectus supplement has been filed with the SEC and is available on their website.

Positive

• Raised approximately $75.2 million in gross proceeds to fund growth initiatives.
• Strengthens financial position through a successful public offering.

Negative

• Potential dilution of existing shares due to the new offering.
• -

WARSAW, Ind., June 22, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the closing of its underwritten public offering of 1,600,000 shares of its common stock at a price to the public of $47.00 per share. Gross proceeds to OrthoPediatrics were approximately $75.2 million, before deducting underwriting discounts and commissions and offering expenses payable by OrthoPediatrics.

Piper Sandler and Stifel acted as joint book-running managers and BTIG, JMP Securities, Needham & Company, and SunTrust Robinson Humphrey acted as co-managers of the offering.

The offering was made pursuant to a shelf registration statement on Form S-3 that became effective on March 27, 2020. The offering was made only by means of a written prospectus and prospectus supplement that form part of the registration statement. A final prospectus supplement and accompanying prospectus has been filed with the SEC and is available on the SEC’s website at www.sec.gov.  Copies of the final prospectus supplement and accompanying prospectus may also be obtained for free from the offices of Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, via telephone at (800) 747-3924 or via email at prospectus@psc.com; or from Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, via telephone at (415) 364-2720 or via email at syndprospectus@stifel.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
tbui@theruthgroup.com / epoalillo@theruthgroup.com

FAQ

What is the public offering price for OrthoPediatrics shares?

The public offering price for OrthoPediatrics shares was $47.00 per share.

How much did OrthoPediatrics raise from the public offering?

OrthoPediatrics raised approximately $75.2 million in gross proceeds from the offering.

Who managed the public offering for OrthoPediatrics?

The public offering was managed by Piper Sandler and Stifel, with assistance from several co-managers.

When did the public offering close for OrthoPediatrics?

The public offering for OrthoPediatrics closed on June 22, 2020.

What is the stock symbol for OrthoPediatrics?

The stock symbol for OrthoPediatrics is KIDS.